24
Just Biotherapeutics started in 2015 with the mission to optimise and produce biologics at a price affordable even for low income countries. For the application of its technological solution, the Seattle-based company received grants for projects worth more than $30m in grants from the Bill & Melinda Gates Foundation.
Under the agreement, Just Biotherapeutics will receive €54m ($60m) upfront from Evotec. In addition, the company is eglible to recieve €27 ($30m) in potential earn outs in the next three years. The acquisition of 100% of the issued and outstanding equity interests of the company will be paid in cash to a syndicate of…